Hale Joshua, Landrum Kelsey R, Agala Chris, Vidri Roberto A, Gleeson Elizabeth, LeCompte Michael T
School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Surg Endosc. 2025 May 9. doi: 10.1007/s00464-025-11755-9.
Radical cholecystectomy (RC) is the standard procedure for gallbladder cancer (GBC) tumors stage TIb or higher. Advances in minimally invasive surgery (MIS) offer the potential for improved outcomes compared to the traditional open surgery. While small series have demonstrated the feasibility of an MIS approach, a detailed comparison of outcomes between the two approaches is lacking.
The National Surgeon Quality Improvement Database (2010-2021) was queried to identify patients undergoing RC for GBC. Patients with T1b or higher disease were included. Thirty-day all-cause mortality and morbidity were evaluated. To assess associations between outcomes and covariates, we estimated risk ratios and risk differences using generalized linear models and adjusted the estimates using inverse propensity of treatment weights.
1303 patients were identified (239 MIS, 1064 Open) with 178 excluded due to the need for biliary reconstruction. There was no difference in the primary outcomes of mortality or major morbidity between the groups with four deaths occurring overall and major morbidity rates of MIS = 2.26% and Open = 2.45% (p = 0.7924). Patients who underwent MIS had significantly fewer days in the hospital (3.00 vs.5.00, p < 0.001). After weighting, the MIS group had significantly fewer blood transfusions (2.12% vs. 6.73%, p = 0.009) and superficial surgical site infections (0.45% vs. 3.29%, p = 0.020).
Our findings contribute to the growing body of evidence supporting MIS for RC as a potential alternative to open resections.
根治性胆囊切除术(RC)是治疗T1b期及以上胆囊癌(GBC)肿瘤的标准术式。与传统开放手术相比,微创手术(MIS)的进展为改善治疗效果提供了可能。虽然小规模研究已证明MIS方法的可行性,但缺乏两种手术方法治疗效果的详细比较。
查询国家外科医师质量改进数据库(2010 - 2021年)以确定接受RC治疗GBC的患者。纳入疾病分期为T1b及以上的患者。评估30天全因死亡率和发病率。为评估治疗效果与协变量之间的关联,我们使用广义线性模型估计风险比和风险差异,并使用治疗权重的逆倾向调整估计值。
共识别出1303例患者(239例MIS,1064例开放手术),其中178例因需要胆道重建而被排除。两组的主要结局死亡率或主要并发症发生率无差异,总体死亡4例,MIS组主要并发症发生率为2.26%,开放手术组为2.45%(p = 0.7924)。接受MIS治疗的患者住院天数明显更少(3.00天对5.00天,p < 0.001)。加权后,MIS组输血明显更少(2.12%对6.73%,p = 0.009),浅表手术部位感染也更少(0.45%对3.29%,p = 0.020)。
我们的研究结果为支持将MIS用于RC作为开放切除术的潜在替代方法的证据不断增加做出了贡献。